AAAAAA

   
Results: 1-25 | 26-50 | 51-64 |
Results: 51-64/64

Authors: Hennig, EM Di Lonardo, A Venuti, A Holm, R Marcante, ML Nesland, JM
Citation: Em. Hennig et al., HPV 16 in multiple neoplastic lesions in women with CINIII, J EXP CL C, 18(3), 1999, pp. 369-377

Authors: Hennig, EM Nesland, JM Di Lonardo, A Venuti, A
Citation: Em. Hennig et al., Multiple primary cancers and HPV infection: Are they related?, J EXP CL C, 18(1), 1999, pp. 53-54

Authors: Hennig, EM Kvinnsland, S Holm, R Nesland, JM
Citation: Em. Hennig et al., Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas, ACTA ONCOL, 38(7), 1999, pp. 931-938

Authors: Hennig, EM Suo, ZH Karlsen, F Holm, R Thoresen, S Nesland, JM
Citation: Em. Hennig et al., HPV positive bronchopulmonary carcinomas in women with previous high-gradecervical intraepithelial neoplasia (CIN III), ACTA ONCOL, 38(5), 1999, pp. 639-647

Authors: Davidson, B Goldberg, I Gotlieb, WH Kopolovic, J Ben-Baruch, G Nesland, JM Berner, A Bryne, M Reich, R
Citation: B. Davidson et al., High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma, CLIN EXP M, 17(10), 1999, pp. 799-808

Authors: Baekelandt, M Kristensen, GB Trope, CG Nesland, JM Holm, R
Citation: M. Baekelandt et al., Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer, ANTICANC R, 19(5C), 1999, pp. 4469-4474

Authors: Kvalheim, G Naume, B Nesland, JM
Citation: G. Kvalheim et al., Minimal residual disease in breast cancer, CANC METAST, 18(1), 1999, pp. 101-108

Authors: Hennig, EM Suo, ZH Thoresen, S Holm, R Kvinnsland, S Nesland, JM
Citation: Em. Hennig et al., Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III)., BREAST CANC, 53(2), 1999, pp. 121-135

Authors: Van Slooten, HJ Van de Vijver, MJ Borresen, AL Eyfjord, JE Valgardsdottir, R Scherneck, S Nesland, JM Devilee, P Cornelisse, CJ Van Dierendonck, JH
Citation: Hj. Van Slooten et al., Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma, J PATHOLOGY, 189(4), 1999, pp. 504-513

Authors: Skomedal, H Kristensen, GB Nesland, JM Borresen-Dale, AL Trope, C Holm, R
Citation: H. Skomedal et al., TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, cdk4, RB, MDM2, and EGFR in cancers of the uterine corpus, J PATHOLOGY, 187(5), 1999, pp. 556-562

Authors: Scheistroen, M Trope, C Pettersen, EO Nesland, JM
Citation: M. Scheistroen et al., p53 protein expression in squamous cell carcinoma of the vulva, CANCER, 85(5), 1999, pp. 1133-1138

Authors: Noodt, BB Berg, K Stokke, T Peng, Q Nesland, JM
Citation: Bb. Noodt et al., Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light, BR J CANC, 79(1), 1999, pp. 72-81

Authors: Suo, Z Emilsen, E Tveit, KM Nesland, JM
Citation: Z. Suo et al., Type 1 protein tyrosine kinases in benign and malignant breast lesions, HISTOPATHOL, 33(6), 1998, pp. 514-521

Authors: Bryne, M Boysen, M Alfsen, CG Abeler, VM Sudbo, J Nesland, JM Kristensen, GB Piffko, J Bankfalvi, A
Citation: M. Bryne et al., The invasive front of carcinomas. The most important area for tumour prognosis?, ANTICANC R, 18(6B), 1998, pp. 4757-4764
Risultati: 1-25 | 26-50 | 51-64 |